The Quantellect read.As of Nov 19, 2026, 4 active firms cover Innoviva Inc: 4 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $34.00 to $46.00, so the covering firms are broadly aligned. The average target of $39.25 sits 113% above the current $18.42. Sentiment has drifted a little more constructive lately, with Sell ratings easing from 1 to 0 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.49 next quarter toward $2.14 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 active firms
Buy
Strong Buy00%
Buy4100%
Neutral00%
Sell00%
Strong Sell00%
Based on 4 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$39.25
+113.1% upside
Average target across 4 active firms as of Nov 19, 2026 vs $18.42 current
Highest Target$46.00
Average Target$39.25
Lowest Target$34.00
Detailed analyst forecasts for INVA
Showing 1–4 of 4 named analysts shown · 4 active firms in the rating projection
As of Nov 19, 2026, 4 of 4 active firms rate INVA a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
INVA EPS & revenue forecast
EPS · NEXT QUARTER
$0.49
Range $0.41 – $0.55 · 5 analysts · -78% YoY
Next period, 5 analysts expect Innoviva Inc to earn $0.49 a share (range $0.41 – $0.55), versus $2.22 a year earlier. Full-year consensus is $0.86, growing to $2.14 the year after.
REVENUE · NEXT QUARTER
$113.1M
Range $103.9M – $123.2M · 5 analysts · +15% YoY
Revenue is expected to reach $113.1M (range $103.9M – $123.2M), +15.4% year-over-year. Full-year consensus is $434.5M, rising to $475.3M next year.
Top analysts covering Innoviva Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on INVA.
#1
Julian Harrison
BTIG · Rank #183
Buy
$42.00+128.0% to target
Overall win rate
41%
+ Follow
#2
Raghuram Selvaraju
HC Wainwright & Co. · Rank #423
Buy
$46.00+149.7% to target
Overall win rate
36%
+ Follow
#3
SS
Steve Seedhouse
Cantor Fitzgerald
Buy
$34.00+84.6% to target
Coverage
—
+ Follow
#4
AH
Asad Haider
Goldman Sachs
Sell
$18.00-2.3% to target
Coverage
—
+ Follow
#5
TA
Trevor Allred
Oppenheimer
Buy
$35.00+90.0% to target
Coverage
—
+ Follow
INVA stock forecast FAQ
What is INVA's average 12-month price target?+
The 4 active firms with a live target average $39.25 for Innoviva Inc over the next 12 months, ranging from a $46.00 high to a $34.00 low, as of Nov 19, 2026.
Is INVA stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 4 active firms as of Nov 19, 2026, 4 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for INVA?+
The Street-high target is $46.00 (HC Wainwright & Co.), and the Street-low is $34.00 (Cantor Fitzgerald). The average of all 4 active-firm targets is $39.25.
How many active Wall Street firms cover INVA?+
4 active firms have a recognized rating on Innoviva Inc as of Nov 19, 2026, and 4 active firms carry a live 12-month price target.
Who is the most accurate analyst covering INVA?+
Among analysts who currently cover INVA, Julian Harrison of BTIG has the strongest overall Quantellect track record (Rank #183). Their current call is Buy with a $42.00 target.
What is Innoviva Inc's projected EPS for next quarter?+
The consensus estimate is $0.49 per share (range $0.41 – $0.55) across 5 analysts. Full-year EPS is projected at $0.86, rising to $2.14 the following year.
How much revenue is Innoviva Inc expected to report next quarter?+
Consensus revenue is $113.1M (range $103.9M – $123.2M). Full-year revenue is projected at $434.5M, growing to $475.3M next year.
Have analysts been upgrading or downgrading INVA lately?+
As of Nov 19, 2026, 4 of 4 active firms rate INVA a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their INVA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.